Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
JBIO · NASDAQ · Pharmaceutical Preparations
Jade Biosciences (JBIO) · oqro.io/stocks/JBIO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$16.14+0.27 (+1.70%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Oct 28, 2026
Franklin Templeton, Inc. now owns 6% of JBIO as a passive investorSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Paradigm Biocapital Advisors LP disclosed a new position in JBIO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bellevue Group AG disclosed a reduced position in JBIO for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Bellevue Group AG disclosed an increased position in JBIO for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Bellevue Group AG disclosed a new position in JBIO for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Ra Capital Management, L.P. disclosed an increased position in JBIO for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Deep Track Capital, LP no longer reported JBIO for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Frazier Life Sciences Management, L.P. no longer reported JBIO for Q4 2025Fund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Frazier Life Sciences Management, L.P. disclosed a reduced position in JBIO for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Deep Track Capital, LP disclosed a reduced position in JBIO for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Deep Track Capital, LP disclosed a new position in JBIO for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Frazier Life Sciences Management, L.P. disclosed a new position in JBIO for Q2 2025SourceInsider trade · Traded May 16, 2025 · Filed May 19, 2025
CEO purchased ~$44K of JBIO shares in the open marketSource